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Abstract 
Purpose: To investigate the antihyperglycaemic and hypolipidemic potential of the methanol extracts of 
leaf, stem and root of Ageratum conyzoides in streptozotocin (STZ)-induced diabetic rats. 
Methods: The extract of each of the plant part was obtained by extraction in methanol. A total of 60 
male Wistar albino rats (30 induced with diabetes and 30 normoglycaemic) were assigned into diabetic 
and normoglycaemic groups of 6 rats each. Methanol extracts of leaf, stem and root of Ageratum 
conyzoides were administered orally at a dose of 100 mg/kg to the rats for a period of 14 days, with 
glibenclamide as the standard drug (1 mg/kg). Fasting blood glucose and lipid profile were determined 
to ascertain the antihyperglycaemic and hypolipidemic activities of the different parts of the plant. 
Results: Ageratum conyzoides significantly (p < 0.05) reduced fasting blood glucose (FBG) levels in 
diabetic rats by 38.71 ± 19.41 % (leaf), 25.64 ± 20.53 % (stem), and 34.76 ± 18.03 % (root) on day 14 of 
the treatment, compared with untreated diabetic rats where FBG increased by 11.33±8.91 %. Total 
cholesterol (leaf, 119.10 ± 8.12 mg/dl; stem, 109.28 ± 8.13 mg/dl) and triglycerides (leaf, 61.71 ± 9.37 
mg/dl; stem, 72.45 ± 3.39 mg/dl) levels were also significantly (p < 0.05) lowered in diabetic rats. Low 
density lipoprotein cholesterol (leaf, 77.21 ± 8.12 mg/dl; stem, 64.76 ± 8.04 mg/dl; root, 79.08 ± 10.61 
mg/dl) levels were significantly (p < 0.05) lowered in all treated diabetic groups compared with the 
untreated diabetic rats (103.19 ± 6.08 mg/dl). 
Conclusion: The results from this study indicate that Ageratum conyzoides has hypoglycaemic and 
hypolipidemic properties in rats, and this probably justifies its reported use in the traditional 
management of diabetes mellitus. 
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Early diagnosis and reduction of hyperglycemia, 
a hallmark of diabetes, can reduce much of the 
excess morbidity and mortality associated with 
diabetes mellitus. Increasing evidence indicates 
that the complications of diabetes are 
preventable by controlling the metabolic 
abnormalities but oral hypoglycaemic drugs 
developed to manage diabetes are not without 
side effects. Problems associated with the 
current diabetic pharmacotherapy such as 
hypoglycaemia, weight gain, lactic acidosis, skin 
reactions, acute porphyria and abdominal 
discomfort [1] have further necessitated the need 
to search for more effective and safer approach 
to pre-diabetic and diabetic management [2]. 
 
Plants provide an alternative strategy in search 
for new drugs. The reducing effect of blood 
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glucose by a large number of plants have been 
confirmed in animal models and clinical studies 
[3]. Ageratum conyzoides is an annual herb with 
long history of traditional medicinal uses in many 
countries in the world. In traditional medicine, 
Ageratum conyzoides is used for the treatment of 
several diseases including diabetes [4]. For 
instance, aqueous extract of the whole part of the 
plant has been used as a dermatological remedy, 
while ethyl acetate extract has been shown to 
possess anti-cancerous and radical scavenging 
properties [5]. Similarly, the anti-inflammatory, 
antifungal and schistosomicidal properties of the 
plant have been reported [6-8]. Studies have also 
demonstrated the antioxidant activity, insecticidal 
activities and larvicidal effect of the plant extracts 
[9,10]. In this study we explored the 
antihyperglycaemic and hypolipidemic potential 
of Ageratum conyzoides in streptozotocin-






Streptozotocin (STZ) and methanol were 
purchased from Sigma Chemical Company St. 
Louis U.S.A. All assay kits were from Randox 
Laboratories Limited UK. All other chemicals 
(sodium citrate, chloroform) and reagents used 
were of analytical grade obtained from reputable 
manufacturers. 
 
Plant collection and identification 
 
Fresh Ageratum conyzoides plants were 
collected from an uncultivated farmland in 
Samaru, Zaria, Kaduna State, Nigeria in the 
month of July 2012. Sample was identified and 
authenticated at the Herbarium Unit of the 
Department of Biological Sciences, Ahmadu 
Bello University, Zaria by Mr. Gallah U.J, a 
taxonomist, where a voucher specimen (no. 261) 




Adult albino rats of either sexes weighing 
between 150 - 200 g were obtained from the 
Animal House, Department of Pharmacology, 
Ahmadu Bello University, Zaria. The animals 
were acclimatized in well ventilated cages under 
ambient environmental conditions for a period of 
two weeks before commencement of experiment. 
They were maintained on grower’s mash (Vital 
Feeds Grand Cereal Plc, Bukuru, Jos, Plateau 
State) and provided with water ad libitum. All the 
experiments were conducted in accordance with 
international laboratory animal use and care 
guidelines [11]. Study protocols and ethical 
issues were approved by the Animal Research 
and Ethical Committee of Ahmadu Bello 
University, Zaria, Nigeria with ref no. 
ABUAREC/124/2012. 
 
Preparation and extraction of plant materials 
 
Fresh Ageratum conyzoides plants were 
separated into leaves, stems and roots, rinsed in 
clean water and dried under ambient 
temperature until brittle. The dry samples were 
ground separately into powder using mortar and 
pestle. Each of the powdered materials (250 g) 
was extracted with 1.0 L of methanol by cold 
maceration for 48 h in large amber bottles with 
intermittent shaking. The crude methanol 
extracts were filtered and concentrated to 
dryness using rotary evaporator at 45 oC. The 
concentrated extracts were stored in air-tight 





Qualitative phytochemical screening for 
alkaloids, carbohydrates, cardiac glycosides, 
anthracene, flavonoids, saponins, tannins, 
steroids and triterpenes was carried out on the 
leaf, stem and root extracts by the methods 
described by Trease and Evans [12]. 
 
Induction of diabetes 
 
Diabetes was induced in rats fasted overnight by 
a single intraperitoneal injection of freshly 
prepared solution of streptozotocin (Sigma 
Chemicals Co., St Loius USA) at 60 mg/kg in 0.1 
M cold citrate buffer pH 4.5. The animals were 
considered as diabetic if the blood glucose 
values of the overnight fasted rats, were > 200 
mg/dl on the third day following streptozotocin 
injection [13]. 
 
Animal grouping and treatment 
 
A total of 60 rats were randomly divided into 10 
groups of 6 rats each as follows: normal control 
(feed and water only), untreated diabetic 
(diabetic control), diabetic + leaf extract (100 
mg/kg), diabetic + stem extract (100 mg/kg), 
diabetic + root extract (100 mg/kg), diabetic + 
glibenclamide (1 mg/kg), normoglycaemic +  leaf 
extract (100 mg/kg), normoglycaemic +  stem 
extract (100 mg/kg), normoglycaemic +  root 
extract (100 mg/kg), normoglycaemic + 
glibenclamide (1 mg/kg) [14]. Treatment was 
orally administered daily for a period of 14 days. 
 
Blood glucose determination 
 
Atawodi et al 
Trop J Pharm Res, May 2017; 16(5): 991  
 
The fasting blood glucose was determined as 
described by Clark and Lyons [15] using 
glucometer. The test is based on the principle 
that the test strip has a small spot impregnated 
with glucose oxidase and other components. The 
glucose in the blood sample reacts with the 
glucose oxidase to form gluconic acid, which 
then reacts with ferricyanide to form 
ferrocyanide. The electrode oxidizes the 
ferrocyanide, and this generates a current 
directly proportional to the glucose concentration. 
The total charge passing through the electrode is 
proportional to the amount of glucose in the 
blood that has reacted with the enzyme. The 
change in this parameter (G) was calculated 
using Eq 1. 
 
G (%) = {(Gf – Gi)/Gi}100 ………….. (1) 
 
where Gi  and Gf are the initial and final fasting 
blood glucose respectively.  
 
Collection of blood for analyses 
 
At the end of 14 days of treatment, the animals 
were anaesthetized with chloroform and 
sacrificed by decapitation. The blood of each 
animal was separately collected in non-
heparinised tubes and allowed to clot. Serum 
was harvested following centrifugation at 3000 
rpm for 15 min and was used for biochemical 
analyses. 
 
Determination of serum total cholesterol (TC) 
 
Cholesterol in the blood is oxidized by 
cholesterol oxidase to yield hydrogen peroxide. 
Serum cholesterol was quantified 
spectrophotometrically by measuring the 
absorbance of the indicator, quinoneimine, 
formed from hydrogen peroxide and 4-
aminoantipyrine in the presence of phenol and 
peroxidase as described by Stein [16].  
 
The assay mixture contained 10 µl of test serum 
and 1 µl of cholesterol reagent in a test tube.  
The mixture was incubated at 37 °C for 5 min in 
a water bath. The absorbance of the sample (At) 
and that of the standard (As) were measured 
against the reagent blank at 500 nm wavelength. 
The values obtained were used to calculate total 
cholesterol concentration as in Eq 2. 
 
TC (mg/dl) = (At/As)C ………….. (2) 
 
where TC = total cholesterol, At = absorbance of 




Determination of serum triglycerides (TG) 
 
The serum triglycerides (TG) level was 
determined by enzymatic method described by 
Stein [16]. One millilitre of the randox TG enzyme 
reagent (containing a mixture of lipases, glycerol-
kinase, ATP, 4-aminophenazone, 4-
chlorophenol, peroxidise, glycerol-3-phosphate 
oxidase and magnesium ions) was dispensed 
into three separately labelled test tubes; 
standard, sample and reagent blank. The 
standard contained 10 µl standard triglyceride, 
the tube labelled sample contained 10 µl test 
serum while that labelled reagent blank was 
empty. The mixture was incubated for 5 min at 
37 °C in a water bath. After the period of 
incubation the absorbance of the sample and 
that of the standard was read against the reagent 
blank within 60 min using a colorimeter at 500 
nm wavelength. The triglyceride concentration 
was calculated as in Eq 3. 
 
TG (mg/dl) = (At/As)C ………….. (3) 
 
where TG = triglycerides, At = absorbance of 
sample and As = absorbance of standard.  
 
Determination of serum high density 
lipoprotein-cholesterol (HDL-C) 
 
Serum level of HDL-C was estimated as 
described by Wacnic and Albers [17]. The Assay 
principle is based on the quantitative precipitation 
of low density lipoproteins (LDL and VLDL) and 
chylomicron fractions by the addition of 0.5 ml of 
reagent 1 (R1) which is made up of phosphor-
tungstic acid and magnesium chloride to 0.2 ml 
of the sample. The resulting mixture from this 
reaction was centrifuged at 4000 rpm for 10 min 
and the supernatant was collected. The 
cholesterol concentration in the HDL fraction, 
which remains in the supernatant was 
determined by adding 1.0 ml of reagent 2 
(cholesterol reagent) into clean test tubes 
containing 0.05 ml of sample supernatant, 0.05 
ml standard supernatant and an empty test tube 
(reagent blank), mixed thoroughly and incubated 
for 30 min at room temperature. The absorbance 
was read against the reagent blank at 500 nm 
within 60 min. 
 
The concentration of HDL-C was calculated as in 
Eq 4.  
 
HDL-C (mg/dl) = (∆At/∆As)C ………….. (4) 
 
where HDL-C = high density lipoprotein 
cholesterol, ∆At = change in absorbance of 
sample, and ∆As = change in absorbance of 
standard. 
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Determination of serum low density 
lipoprotein-cholesterol (LDL-C)   
 
The serum level of low density lipoprotein-
cholesterol (LDL-C) was estimated as described 
by Friedewald et al as in Eq 5 [18]. 
 
LDL-C (mg/dl) = TC – TG/5 – HDL-C …….. (5) 
 
where LDL-C = low density lipoprotein 
cholesterol, TC = total cholesterol, TG = 





The data were analyzed using ANOVA and 
expressed as mean ± SD except where 
otherwise stated. The differences in means were 
compared using Duncan Multiple Range Test. A 
value of p < 0.05 was considered to indicate a 




Extract yield  
 
The yields of methanol leaf, stem and root  
extracts of Ageratum conyzoides were 7.65%, 
4.70% and 2.85%, respectively. 
  
Phytochemical constituents of Ageratum 
conyzoides 
 
The phytochemical screening revealed the 
presence of alkaloids, carbohydrates, cardiac 
glycosides, flavonoids, saponins, tannins, 
steroids and triterpenes in the extracts (Table 1). 
 
Effect of different parts of Ageratum 
conyzoides on fasting blood glucose (FBG) 
 
Ageratum conyzoides significantly (p < 0.05) 
reduced blood glucose levels in treated diabetic 
groups in comparison with the diabetic control. 
On the 14th day of the experiment, the fasting 
blood glucose (FBG) showed 38.71, 25.64, 34.76 
and 34.39 % reduction in blood glucose by the 
leaf, stem, root and glibenclamide treated 
diabetic groups respectively against the increase 
of 11.33 % seen in the negative control group. 
The leaf extract had the highest reducing effect 
on fasting blood glucose. There was no 
significant (p > 0.05) change in blood glucose 
levels of normoglycaemic rats treated with 
extracts of Ageratum conyzoides (Table 2). 
 
              Table 1: Phytochemical constituents of methanol extracts of Ageratum conyzoides 
 
Phytochemical Leaf Stem Root 
Alkaloids + + + 
Carbohydrates                + + + 
Cardiac glycosides             + + + 
Anthracene - - - 
Flavonoids + + + 
Saponins       + + + 
Tannins + + + 
Steroid + - - 
Triterpenes + + + 
+ = present; - = absent 
 
Table 2: Fasting blood glucose level of streptozotocin-induced diabetic and normoglycaemic rats treated with 100 




Fasting blood glucose (mg/dL) % Change 
Day 0 Day 7 Day 14 (Day 14) 
Normal Control 87.83±13.85a 79.17±3.54a 86.00±9.70a +0.91±23.33
c 
Diabetic + Untreated 284.33±55.23b 310.17±61.72c 315.83±62.37c +11.33±8.91
c 
Diabetic + Leaf 321.50±94.14b 255.33±93.61bc 192.67±82.2b -38.71±19.41
a 
Diabetic + Stem 254.50±61.10b 218.00±63.69b 184.80±58.34b -25.64±20.53
ab 
Diabetic + Root 302.67±45.72 b 270.50±63.43bc 202.33±82.69 b -34.76±18.03
a 
Diabetic + Glib 294.33±49.31b 241.67±62.78bc 188.83±64.69b -34.39±23.33a 
Normoglycaemic+Leaf 88.17±19.15a 80.33±19.34a 82.83±5.27a -3.27±15.95bc 
Normoglycaemic+Stem 90.00±9.42a 83.17±11.57a 83.00±8.90a -7.46±8.66bc 
Normoglycaemic+Root 98.00±12.14a 91.33±11.86a 93.33±8.43a -3.25±17.82bc 
Normoglycaemic+Glib 94.50±13.49a 88.33±9.41a 90.00±7.84a -3.54±13.27bc 
Values are means ± SD, values with different superscripts down the column are significantly different (p < 0.05). a 
p < 0.01, b p < 0.001, c p < 0.0001. Values are presented as mean ± SD (n = 6) for each group. Values are 
statistically significant compared to control group at p < 0.05 
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Table 3: Lipid profile of streptozotocin-induced diabetic and normoglycaemic rats treated with 100 mg/kg 




Lipid profile (mg/dL)  
TC TG HDL-C LDL-C 
Normal Control 91.84±3.70ab 59.05±3.53ab 30.27±0.47b 49.76±3.52
ab 
Diabetic + Untreated 148.88±7.41e 100.82±11.17d 25.52±1.04a 103.19±6.08
e 
Diabetic + Leaf 119.10±8.12cd 61.71±9.37ab 29.55±1.00b 77.21±8.12
cd 
Diabetic + Stem 109.28±8.13bcd 72.45±3.39abc 30.03±0.52b 64.76±8.04
bcd 
Diabetic + Root 128.77±10.48de 95.06±8.73cd 30.67±1.57b 79.08±10.61
cd 
Diabetic + Glib 127.99±5.63de 81.49±11.69bcd 29.39±0.94b 82.31±5.94
d 
Normoglycaemic+Leaf 95.80±1.36ab 62.71±6.90ab 31.73±0.68b 51.53±2.61
ab 
Normoglycaemic+Stem 95.36±11.06ab 49.78±7.45a 32.64±1.20b 52.77±10.74
ab 
Normoglycaemic+Root 103.92±2.53bc 72.63±2.08abc 31.56±1.78b 57.84±2.67
abc 
Normoglycaemic+Glib 77.92±6.09a 60.67±9.36ab 29.13±1.90b 36.65±7.89
a 
Values are means ± sd, n = 6, values with different superscripts down the column are significantly different (p < 
0.05). a p < 0.01, b p < 0.001, c p < 0.0001. TC: Total cholesterol; TG: Triglycerides; HDL-C: High density 




Figure 1: Weight change of (a) normoglycaemic rats treated with 100 mg/kg methanol leaf, stem and root 
extracts of Ageratum conyzoides and (b) streptozotocin-induced diabetic rats treated with 100mg/kg methanol 
leaf, stem and root extracts of Ageratum conyzoides. Values are presented as mean ± SD (n = 6) for each group. 
Values are statistically significant compared to control group at p < 0.05. NC – normal control, NL – 
normoglycaemic+leaf, NS – normoglycaemic+stem, NR – normoglycaemic+root, NG – 
normoglycaemic+glibenclamide, NC – normal control, DC – diabetic control, DL – diabetic+leaf, NS – 
diabetic+stem, DR – diabetic+root, DG – diabetic+glibenclamide 
 
Effect of methanol extracts of Ageratum 
conyzoides on serum lipids  
 
There was significant (p < 0.05) reduction in total 
cholesterol (TC), triglycerides (TG) and low 
density lipoprotein cholesterol (LDL-C) 
concentrations of all diabetic groups treated with 
extracts when compared with the negative 
control (Table 3). High density lipoprotein 
cholesterol (HDL-C) concentration was 
significantly (p < 0.05) increased in treated 
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diabetic group in comparison with the negative 
control. 
 
Effect of methanol extracts of Ageratum 
conyzoides on rat body weight  
 
Generally, there was decline in the weights of 
streptozotocin-induced diabetic rats but 
treatment with the extracts shows ameliorative 
effect (Figure 1). There was significant (p < 0.05) 
improvement in the body weight of treated 
diabetic groups compared with the diabetic 
control; the final body weights of streptozotocin 
induced diabetic rats treated with the extracts 
were significantly increased (p < 0.05) in 




Plant based herbal drugs are emerging as the 
primary components of holistic approaches to 
diabetes management. Recently, the search for 
appropriate hypoglycaemic agents using animal 
models in diabetes research has been focused 
on plants used in traditional medicine partly 
because of leads provided by traditional 
medicines to natural products that may be better 
treatment than the currently used drugs [2,3]. 
 
Phytochemical components have been 
implicated as responsible for some anti-diabetic 
activity of some plant extracts [2,4]. These 
natural components may act separately or 
synergistically to cause the global hypoglycaemic 
effect [2]. In the present study, phytochemicals of 
antidiabetic importance found in Ageratum 
conyzoides include alkaloids, carbohydrates, 
cardiac glycosides, flavonoids, saponins, tannins, 
steroids and triterpenes. Alkaloids inhibit α-
glucosidase and decrease glucose transport 
through the intestinal epithelium. 
 
Flavonoids suppress  the  glucose  level,  reduce  
plasma cholesterol  and  triglycerides  
significantly  and  increase hepatic glucokinase 
activity probably by enhancing the insulin release 
from pancreatic islets. Tannin reduce blood 
glucose level in a dose dependent manner. 
Triterpenoids and saponins stimulates the 
release of insulin and blocks the formation of 
glucose in the blood stream. Cardiac glycosides 
stimulate insulin secretion form islets cells. 
Steroids reduced the blood glucose level and 
restoring the insulin levels [19,20] 
 
The reduction observed in fasting blood glucose 
of treated diabetic rats is in agreement with 
previous studies [21,22]. Earlier, it has been 
reported that the mode of reduction in blood 
glucose could be due to some active 
phytoconstituents having insulinomimetic or 
insulin secretagogues activity [23]. The 
mechanism of action of Ageratum conyzoides 
could be both pancreatic and extrapancreatic. 
The latter might involve the stimulation of 
peripheral glucose utilization. This is in contrast 
to glibenclamide which stimulates insulin release 
from the beta-cell of the pancreas and is only 
efficient when damage to the beta-cell is 
moderate. Flavonoids, a component of Ageratum 
conyzoides are known to regenerate the 
damaged beta-cells in diabetic mice [24,25]. 
Ageratum conyzoides may also act by preventing 
the death of β-cells and/or permit recovery of 
partially destroyed β-cells [26]. 
 
Several components  of  plant  extracts,  such  as  
fibre [27],  saponins  [28]  and  flavonoids [29], 
possess antihyperlipidemic effects. The ability of 
Ageratum conyzoides extract in reducing serum 
lipids could be explained on the basis of insulin 
releasing capacity of its phytoconstituents. 
Insulin inhibits lipolysis and increases uptake of 
fatty acids into adipose tissue and triglyceride 
synthesis. In insulin-deficient diabetes, lipolysis is 
not inhibited and this results to hyperlipidemia. 
Lipid abnormalities accompanying atheroscle-
rosis is the major cause of cardiovascular 
disease in diabetes with high levels of TC and 
LDL as major coronary risk factors [30]. HDL-
Cholesterol, an antiatherogenic lipoprotein  
transports cholesterol  from peripheral  tissues  
into  the  liver and  thereby  acts  as  a  protective  
factor  against coronary  heart  disease [21]. TC 
and TG were significantly lowered in diabetic rats 
treated with leaf and stem extracts of Ageratum 
conyzoides. LDL-C levels were also significantly 
lowered in all treated diabetic groups. This was 
accompanied by a corresponding significant 
increase in HDL-C (cardioprotective lipid) levels. 
These results are in agreement with previous 
findings [21,31]. 
 
Type 1 diabetes mellitus is associated with loss 
of body weight due to increase muscle wasting 
and loss of tissue proteins.  Induction of diabetes 
with streptozotocin is a simulation of type 1 
diabetes. Treatment had significant ameliorative 
effect on the weights of diabetic rats comparable 
to the positive control which received the 
standard drug. This is a clear demonstration of 
the potential of Ageratum conyzoides in 




The significant activities of Ageratum conyzoides 
seen in this study may be due to the presence of 
phytochemicals, such as flavonoids, which have 
been shown to possess antidiabetic and 
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antioxidant properties. Hence, this justifies the 
use of the plant in traditional medicine for the 
management of diabetes, and should therefore 
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